Shilpa Pharma Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 10.00 Cr
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1,150.50 Cr
- Satisfied Charges ₹ 73.00 Cr
- Revenue Growth %
- Profit Growth -1229.81%
- Ebitda 86.99%
- Net Worth 10.40%
- Total Assets 18.18%
About Shilpa Pharma Lifesciences
Shilpa Pharma Lifesciences Limited (SPLL) is a Public Limited Indian Non-Government Company incorporated in India on 08 May 2020 (Four years and ten months 19 days old ). Its registered office is in Raichur, Karnataka, India.
The Corporate was formerly known as Shilpa Corporate Holdings Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 10.00 Cr.
The company currently has active open charges totaling ₹1,150.50 Cr. The company has closed loans amounting to ₹73.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Shilpa Pharma Lifesciences Limited India are Alpesh Dalal as Cfo, Reetu Sharma as Company Secretary, and Santosh Mahil as Ceo. Vishnukanth Bhutada, Ramakant Innani, Kalakota Sharath, and Two other members serve as directors at the Company.
Company Details
- Location
Raichur, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100KA2020PLC134081
- Company No.
134081
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 May 2020
- Date of AGM
16 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Pharma
Who are the key members and board of directors at Shilpa Pharma Lifesciences?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishnukanth Bhutada  | Managing Director | 08-May-2020 | Current |
| Alpesh Dalal | CFO | 12-Aug-2022 | Current |
| Reetu Sharma | Company Secretary | 12-Aug-2022 | Current |
| Santosh Mahil | CEO | 27-Apr-2024 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Keshav Bhutada | Director | 09-Mar-2022 | Current |
| Ramakant Innani | Director | 08-May-2020 | Current |
| Kalakota Sharath | Director | 29-Mar-2022 | Current |
| Anita Bandyopadhyay | Director | 12-Aug-2022 | Current |
Financial Performance of Shilpa Pharma Lifesciences.
Shilpa Pharma Lifesciences Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1229.81% decrease in profit. The company's net worth Soared by an impressive increase of 10.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shilpa Pharma Lifesciences?
In 2023, Shilpa Pharma Lifesciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vashi Integrated Solutions LimitedAnita Bandyopadhyay is a mutual person
Sravathi Ai Technology Private LimitedKeshav Bhutada is a mutual person
Sravathi Advance Process Technologies Private LimitedVishnukanth Bhutada and Ramakant Innani are mutual person
Inm Technologies Private LimitedVishnukanth Bhutada and Ramakant Innani are mutual person
Inm Nuvent Paints Private LimitedVishnukanth Bhutada and Ramakant Innani are mutual person
Ami Organics LimitedAnita Bandyopadhyay is a mutual person
Charges (Loans)
Open Charges
₹1,150.50 Cr
Satisfied Charges
₹73.00 Cr
Charges Breakdown by Lending Institutions
- Others : 1000.50 Cr
- Axis Bank Limited : 150.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2024 | Others | ₹450.00 Cr | Open |
| 04 Aug 2023 | Others | ₹450.00 Cr | Open |
| 27 Feb 2023 | Others | ₹5.00 M | Open |
| 27 Oct 2022 | Axis Bank Limited | ₹150.00 Cr | Open |
| 19 Oct 2022 | Others | ₹100.00 Cr | Open |
How Many Employees Work at Shilpa Pharma Lifesciences?
Shilpa Pharma Lifesciences has a workforce of 1200 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shilpa Pharma Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shilpa Pharma Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Shilpa Pharma Lifesciences
Recent activity within the organization
- Charges
A charge registered on 31 May 2023 via Charge ID 100726722 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 10 Oct 2024.
- Annual General Meeting
Shilpa Pharma Lifesciences Limited last Annual general meeting of members was held on 16 Sep 2024 as per latest MCA records.
- Charges
A charge with Others of Rs. 0.50 Cr registered on 27 Feb 2023 with Charge ID 100684998 was modified on 30 May 2024.
- Director Appointment
Santosh Kumar Mahil was appointed as a Ceo was appointed as a Ceo on 27 Apr 2024 & has been associated with this company since 11 months .
- Balance Sheet
Shilpa Pharma Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
- Charges
A charge with Others amounted to Rs. 450.00 Cr with Charge ID 100928819 was registered on 30 Mar 2024.
Recent News, Updates & Announcement
- Shilpa Medicare gets 2 observations from USFDA for Telangana facility.
"The inspection concluded with two observations. There were no repeat observations or Data Integrity (DI) related observations," the company added. .
- Shilpa Medicare gets 5 USFDA observations for Raichur facility.
"We have received Form 483 with five observations, with no repeat observations and any data integrity observations. The observations are mostly procedural in nature," the Shilpa Medicare... .
- Shilpa Medicare's Irinotecan Injection Receives USFDA Approval for Colon and Rectum Cancer Treatment, US Market Valued at $18 Million.
Shilpa Medicare gets USFDA approval for Irinotecan injection to treat cancer. Yay! It's used for colon or rectum cancer and the US market is worth $18 million. #winning #cancerfighter.
Frequently asked questions
What is the Incorporation or founding date of Shilpa Pharma Lifesciences Limited?
Shilpa Pharma Lifesciences Limited was incorporated on 08 May 2020.
What is authorized share capital and paid-up capital of Shilpa Pharma Lifesciences Limited?
The authorized share capital of Shilpa Pharma Lifesciences Limited is ₹ 20.00 Cr and paid-up capital is ₹ 10.00 Cr.
Who are the current board members & directors of Shilpa Pharma Lifesciences Limited?
Currently 8 directors are associated with Shilpa Pharma Lifesciences Limited.
- Vishnukanth Chaturbhuj Bhutada
- Ramakant Innani
- Kalakota Reddy Sharath
- Keshav Bhutada
- Anita Bandyopadhyay
- Alpesh Maheshkumar Dalal
- Reetu Sharma
- Santosh Kumar Mahil
What is the registered address of Shilpa Pharma Lifesciences Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Shilpa Pharma Lifesciences Limited is 12-6-214/A-1 Shilpa House Hyderabad Road, India, Raichur, Karnataka, 584135.
What is the corporate identification number (CIN) and company number of Shilpa Pharma Lifesciences Limited?
The corporate identification number (CIN) of Shilpa Pharma Lifesciences Limited is U24100KA2020PLC134081 and the company number is 134081 as per Ministry of Corporate Affairs (MCA).
What is the official website of Shilpa Pharma Lifesciences Limited?
The Official website of Shilpa Pharma Lifesciences Limited is https://www.vbshilpa.com
How many employees does Shilpa Pharma Lifesciences Limited currently have?
As Per 2022 financial reports, 1200 employees are currently employed by Shilpa Pharma Lifesciences Limited.
What change has been observed in the net worth of Shilpa Pharma Lifesciences Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Shilpa Pharma Lifesciences Limited has experienced an upsurge of 10.40%.
What are the total open charges for Shilpa Pharma Lifesciences Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Shilpa Pharma Lifesciences Limited amount to ₹ 1,150.50 Cr.
When was the last Balance Sheet of Shilpa Pharma Lifesciences Limited filed with the ROC?
The most recent Balance Sheet for Shilpa Pharma Lifesciences Limited was filed with the ROC on 31 Mar 2024.